GLACTONE PHARMA AB
Glactone Pharma is founded on research that has demonstrated that the natural product galiellalactone can inhibit the growth of prostate cancer cells. With these results as the starting point the company has focused on discovering and developing novel drug-like compounds that display efficacious and selective STAT3 inhibition in vitro and in specific immune-oncology and prostate cancer models.
GLACTONE PHARMA AB
Industry:
Biotechnology Pharmaceutical
Founded:
2012-01-01
Address:
Helsingborg, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.glactone.com
Status:
Active
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS PHP Gravatar Profiles
Similar Organizations
Origin
Origin is a privately held, clinical-stage biotechnology company.
AlloCyte Pharmaceuticals AG
AlloCyte Pharmaceuticals AG (AlloCyte) is a privately held Swiss company founded in November 2011.
Biopredic International
Biopredic International is a French privately-owned biotechnology company founded in 1993.
Forward Pharma
Forward Pharma is a privately held biotechnology company, founded in 2005 in Copenhagen, Denmark.
Gubra
Gubra is a privately-held biotech company
Current Employees Featured
Official Site Inspections
http://www.glactone.com Semrush global rank: 5.35 M Semrush visits lastest month: 1.56 K
- Host name: www16.aname.net
- IP address: 89.221.250.16
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Glactone Pharma AB"
Glactone Pharma AB - Crunchbase Company Profile & Funding
Glactone Pharma AB is a privately held Swedish biotech company founded in 2012See details»
Glactone Pharma raises 5,5 MSEK – Aqilion
Jan 24, 2014 The P.U.L.S. organization consists of an operative part and approximately thirty partners with extensive experience from research, development and commercialization in life …See details»
Glactone Pharma - PitchBook
Nov 20, 2017 Information on acquisition, funding, cap tables, investors, and executives for Glactone Pharma. Use the PitchBook Platform to explore the full profile.See details»
Glactone Pharma announces appointments to new Scientific …
Feb 4, 2016 Aqilion executes it’s development programs in a partly virtual organization in close collaboration with selected partners, with specific expertise in drug development. AQILION AB …See details»
Glactone Pharma - Craft
Glactone Pharma is a biotech company. It develops a pipeline of STAT3 (signal transducer and activator of transcription 3) inhibitors for the use in immuno-oncology and for the treatment of …See details»
Glactone Pharma AB - LinkedIn
Glactone Pharma AB | 31 followers on LinkedIn. ... Kenvue Personal Care Product Manufacturing Skillman, New JerseySee details»
Glactone Pharma CEO and Key Executive Team | Craft.co
Glactone Pharma's Chairman is Jan Törnell. Other executives include Anders Bjartell, Board Member; Jeanette Folking, Board Member and 3 others. See the full leadership team at Craft.See details»
PULS-bolagen Laccure och Glactone tar in nytt kapital
Jan 15, 2014 Nyligen genomfördes nyemissioner i två projektbolag i P.U.L.S, Sveriges ledande life science-inkubator. Laccure AB finansieras med 12,3 MSEK för att optimera …See details»
Glactone Pharma - Products, Competitors, Financials, Employees ...
Glactone Pharma is developing a drug for the treatment of castration resistant prostate cancer. Use the CB Insights Platform to explore Glactone Pharma's full profile.See details»
Glactone Pharma - Company Profile - Tracxn
Feb 22, 2025 Glactone Pharma - STAT3 inhibitors as immunotherapy for prostate cancer. Raised funding over 2 rounds from 2 investors. Glactone Pharma has 199 competitors.See details»
Glactone Pharma AB – COBIOE
Directory Through Value Chain Role of stakeholders in the value chain. Interactive map Explore geolocated information. News & Events Open menuSee details»
Glactone Pharma is awarded financing from VINNOVA – Aqilion
Dec 14, 2015 Glactone Pharma has been awarded financing from the VINNOVA, Sweden’s Innovation Agency, for a new innovation project. The project is aimed at developing methods …See details»
L'actone - Crunchbase Company Profile & Funding
Organization. L'actone . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 90 …See details»
Glactone Pharma Receives New Funding From Vinnova
Nov 20, 2017 Glactone receives new funding from Vinnova In strong competition and after external examination, Glactone Pharma has been awarded a SEK 886,500 grant (approx. …See details»
Startup Glactone Pharma develops prostate cancer drug
Glactone Pharma is a new project company within PULS, Sweden´s largest private incubator in life science. Glactone Pharma develops a new drug against castration-resistant prostate …See details»
Startup Glactone Pharma develops prostate cancer drug
Nov 22, 2012 Glactone Pharma is a new project company within PULS, Sweden´s largest private incubator in life science. Glactone Pharma develops a new drug against castration …See details»
WHO | JECFA - World Health Organization
Publications from the World Health Organization. Home; Evaluations of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) Contact; delta-GLUCONOLACTONE. AddThis …See details»
Startup Glactone Pharma develops prostate cancer drug - Nordic …
Jan 21, 2014 Glactone Pharma is a new project company within PULS, Sweden´s largest private incubator in life science. Glactone Pharma develops a new drug against castration-resistant …See details»
Why Oxy’s Acquisition Of Holocene Signals A Maturing Carbon
12 hours ago Occidental’s Big Bet on Liquid Sorbents. This isn’t Occidental’s first rodeo in DAC. Less than two years ago, they made headlines with a $1.1 billion acquisition of Carbon …See details»
Glactone Pharma receives funding from Vinnova – Aqilion
In strong competition and after external examination, Glactone Pharma has been awarded a Vinnova (Sweden’s Innovation Agency) grant for innovative startup companies. The funded …See details»